Cargando…

High-altitude Hypoxia Influences the Activities of the Drug-Metabolizing Enzyme CYP3A1 and the Pharmacokinetics of Four Cardiovascular System Drugs

(1) Background: High-altitude hypoxia has been shown to affect the pharmacokinetic properties of drugs. Although there is a high incidence of cardiovascular disease among individuals living in high-altitude areas, studies on the effect of high-altitude hypoxia on the pharmacokinetic properties of ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Junbo, Duan, Yabin, Duo, Delong, Yang, Jianxin, Bai, Xue, Liu, Guiqin, Wang, Qian, Wang, Xuejun, Qu, Ning, Zhou, Yang, Li, Xiangyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612038/ https://www.ncbi.nlm.nih.gov/pubmed/36297415 http://dx.doi.org/10.3390/ph15101303

Ejemplares similares

Regulation of CYP450 and drug transporter mediated by gut microbiota under high-altitude hypoxia
por: Bai, Xue, et al.
Publicado: (2022)

Changes in the Gut Microbiota of Rats in High-Altitude Hypoxic Environments
por: Bai, Xue, et al.
Publicado: (2022)

Pharmacokinetics of Acetaminophen and Metformin Hydrochloride in Rats After Exposure to Simulated High Altitude Hypoxia
por: Zhu, Jun-bo, et al.
Publicado: (2021)

The role of sex, age and genetic polymorphisms of CYP enzymes on the pharmacokinetics of anticholinergic drugs
por: Trenaman, Shanna C., et al.
Publicado: (2021)

Regulation of High-Altitude Hypoxia on the Transcription of CYP450 and UGT1A1 Mediated by PXR and CAR
por: Duan, Ya-bin, et al.
Publicado: (2020)

Effects of intestinal flora on the pharmacokinetics and pharmacodynamics of aspirin in high-altitude hypoxia
por: Sun, Yuemei, et al.
Publicado: (2020)

Changes in CYP3A4 Enzyme Expression and Biochemical Markers Under Acute Hypoxia Affect the Pharmacokinetics of Sildenafil
por: Zhang, Juanhong, et al.
Publicado: (2022)

Physiologically Based Pharmacokinetic (PBPK) Modeling of Clopidogrel and Its Four Relevant Metabolites for CYP2B6, CYP2C8, CYP2C19, and CYP3A4 Drug–Drug–Gene Interaction Predictions
por: Loer, Helena Leonie Hanae, et al.
Publicado: (2022)

Drug–Drug Interactions Involving Intestinal and Hepatic CYP1A Enzymes
por: Klomp, Florian, et al.
Publicado: (2020)

Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug–Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach
por: Fuhr, Laura Maria, et al.
Publicado: (2021)

Physiologically based pharmacokinetic modeling of tacrolimus for food–drug and CYP3A drug–drug–gene interaction predictions
por: Loer, Helena Leonie Hanae, et al.
Publicado: (2023)

Effects of tomato juice on the pharmacokinetics of CYP3A4-substrate drugs
por: Ohkubo, Atsuko, et al.
Publicado: (2017)

Drug Transporters ABCB1 (P-gp) and OATP, but not Drug-Metabolizing Enzyme CYP3A4, Affect the Pharmacokinetics of the Psychoactive Alkaloid Ibogaine and its Metabolites
por: F. Martins, Margarida L., et al.
Publicado: (2022)

Effects of salidroside on rat CYP enzymes by a cocktail of probe drugs
por: Wei, Yan-Li, et al.
Publicado: (2018)

Physiologically‐Based Pharmacokinetic Modeling for the Prediction of CYP2D6‐Mediated Gene–Drug–Drug Interactions
por: Storelli, Flavia, et al.
Publicado: (2019)

Physiologically‐based pharmacokinetic modeling to predict CYP3A4‐mediated drug‐drug interactions of finerenone
por: Wendl, Thomas, et al.
Publicado: (2021)

Evaluation of CYP2C19-Mediated Pharmacokinetic Drug Interaction of Tegoprazan, Compared with Vonoprazan or Esomeprazole
por: Yang, Eunsol, et al.
Publicado: (2023)

A Four-Way Comparison of Cardiac Function with Normobaric Normoxia, Normobaric Hypoxia, Hypobaric Hypoxia and Genuine High Altitude
por: Boos, Christopher John, et al.
Publicado: (2016)

Prediction of Cyclosporin-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Model Characterizing Interplay of Drug Transporters and Enzymes
por: Yang, Yiting, et al.
Publicado: (2020)

Assessing Drug Interaction and Pharmacokinetics of Loxoprofen in Mice Treated with CYP3A Modulators
por: Paudel, Sanjita, et al.
Publicado: (2019)

Genetic polymorphisms of the drug-metabolizing enzyme CYP2J2 in a Tibetan population
por: Cao, Peilong, et al.
Publicado: (2018)

Evaluation of drug–drug interaction potential for pemigatinib using physiologically based pharmacokinetic modeling
por: Ji, Tao, et al.
Publicado: (2022)

Insights into the pharmacodynamics and pharmacokinetics of meldonium after exposure to acute high altitude
por: Liu, Fengying, et al.
Publicado: (2023)

Physiological and genetic convergence supports hypoxia resistance in high-altitude songbirds
por: Xiong, Ying, et al.
Publicado: (2020)

Whole-genome sequencing of six dog breeds from continuous altitudes reveals adaptation to high-altitude hypoxia
por: Gou, Xiao, et al.
Publicado: (2014)

Physiologically‐based pharmacokinetic modeling of quinidine to establish a CYP3A4, P‐gp, and CYP2D6 drug–drug–gene interaction network
por: Feick, Denise, et al.
Publicado: (2023)

In vitro investigations into the roles of CYP450 enzymes and drug transporters in the drug interactions of zanubrutinib, a covalent Bruton's tyrosine kinase inhibitor
por: Zhang, Heather, et al.
Publicado: (2021)

Physiologically‐based pharmacokinetic modeling to predict drug interactions of lemborexant with CYP3A inhibitors
por: Ueno, Takashi, et al.
Publicado: (2021)

HIF2A Variants Were Associated with Different Levels of High-Altitude Hypoxia among Native Tibetans
por: Basang, Zhuoma, et al.
Publicado: (2015)

Physiologically-Based Pharmacokinetic Modeling Characterizes the CYP3A-Mediated Drug-Drug Interaction Between Fluconazole and Sildenafil in Infants
por: Salerno, Sara N., et al.
Publicado: (2020)

A Physiologically Based Pharmacokinetic and Pharmacodynamic Model of the CYP3A4 Substrate Felodipine for Drug–Drug Interaction Modeling
por: Fuhr, Laura Maria, et al.
Publicado: (2022)

Physiologically-based pharmacokinetic modeling to predict drug-drug interaction of enzalutamide with combined P-gp and CYP3A substrates
por: Otsuka, Yukio, et al.
Publicado: (2023)

Identification and drug metabolic characterization of four new CYP2C9 variants CYP2C9*72-*75 in the Chinese Han population
por: Zhao, Fang-Ling, et al.
Publicado: (2022)

Drugs impact on CYP-450 enzyme family: A pharmacogenetical study of response variation
por: Kalra, Kapil, et al.
Publicado: (2009)

Polymorphisms of drug-metabolizing enzyme CYP2E1 in Chinese Uygur population
por: Zhu, Linhao, et al.
Publicado: (2018)

SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions
por: Preissner, Saskia, et al.
Publicado: (2010)

Interaction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of Lovastatin
por: Chen, Chia-Hao, et al.
Publicado: (2012)

Pharmacokinetic interaction between rhynchopylline and pellodendrine via CYP450 enzymes and P-gp
por: Meng, Qingzhen, et al.
Publicado: (2021)

A clinical drug–drug interaction study to evaluate the effect of a proton-pump inhibitor, a combined P-glycoprotein/cytochrome 450 enzyme (CYP)3A4 inhibitor, and a CYP2C9 inhibitor on the pharmacokinetics of vismodegib
por: Malhi, Vikram, et al.
Publicado: (2016)

Impact of quercetin-induced changes in drug-metabolizing enzyme and transporter expression on the pharmacokinetics of cyclosporine in rats
por: Liu, Yani, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_vgh0ngkah9dq8cpei1r051vgs8